123 related articles for article (PubMed ID: 30362319)
1. Meta-Analysis of Association between PALB2 Polymorphisms and Breast Cancer.
Dianatpour A; Faramarzi S; Ghafouri-Fard S
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2897-2903. PubMed ID: 30362319
[TBL] [Abstract][Full Text] [Related]
2. Association between rs120963, rs152451, rs249935, rs447529, rs8053188, and rs16940342 Polymorphisms in the PALB2 Gene and Breast Cancer Susceptibility: A Meta-Analysis.
Wu Y; Dong X; Wang Y; Wang Q; Gu H; Huang W
Oncol Res Treat; 2018; 41(12):780-786. PubMed ID: 30458447
[TBL] [Abstract][Full Text] [Related]
3. Role of PALB2 Polymorphisms with Regard to Susceptibility to Female Breast Cancer Risk in the Chinese Population.
Jiang W; Zhuang C; Zheng L; Wang X
Genet Test Mol Biomarkers; 2016 May; 20(5):229-34. PubMed ID: 26981788
[TBL] [Abstract][Full Text] [Related]
4. Association of common PALB2 polymorphisms with breast cancer risk: a case-control study.
Chen P; Liang J; Wang Z; Zhou X; Chen L; Li M; Xie D; Hu Z; Shen H; Wang H
Clin Cancer Res; 2008 Sep; 14(18):5931-7. PubMed ID: 18794107
[TBL] [Abstract][Full Text] [Related]
5. Five common single nucleotide polymorphisms in the PALB2 gene and susceptibility to breast cancer in eastern Chinese population.
Cao AY; Yu KD; Yin WJ; Jin W; Di GH; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2010 Aug; 123(1):133-8. PubMed ID: 19921424
[TBL] [Abstract][Full Text] [Related]
6. Common variants in the PALB2 gene confer susceptibility to breast cancer: a meta-analysis.
Zhang YX; Wang XM; Kang S; Li X; Geng J
Asian Pac J Cancer Prev; 2013; 14(12):7149-54. PubMed ID: 24460267
[TBL] [Abstract][Full Text] [Related]
7. Study on TFF1 and PALB2 gene variants associated with gastric carcinoma risk in the Chinese Han population.
Zou W; Zhang Q; Sun R; Li X; He S
Cancer Epidemiol; 2023 Apr; 83():102333. PubMed ID: 36758349
[TBL] [Abstract][Full Text] [Related]
8. [PALB2, a major susceptibility gene for breast cancer].
Piffer A; Luporsi E; Mathelin C
Gynecol Obstet Fertil Senol; 2018 Nov; 46(10-11):701-705. PubMed ID: 30243941
[TBL] [Abstract][Full Text] [Related]
9. Germline mutations of PALB2 gene in a sequential series of Chinese patients with breast cancer.
Zhang K; Zhou J; Zhu X; Luo M; Xu C; Yu J; Deng M; Zheng S; Chen Y
Breast Cancer Res Treat; 2017 Dec; 166(3):865-873. PubMed ID: 28825143
[TBL] [Abstract][Full Text] [Related]
10. A high frequency of PALB2 mutations in Jamaican patients with breast cancer.
Lerner-Ellis J; Donenberg T; Ahmed H; George S; Wharfe G; Chin S; Lowe D; Royer R; Zhang S; Narod S; Hurley J; Akbari MR
Breast Cancer Res Treat; 2017 Apr; 162(3):591-596. PubMed ID: 28194609
[TBL] [Abstract][Full Text] [Related]
11. Targeted massively parallel sequencing characterises the mutation spectrum of PALB2 in breast and ovarian cancer cases from Poland and Ukraine.
Myszka A; Nguyen-Dumont T; Karpinski P; Sasiadek MM; Akopyan H; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Kitsera N; Siekierzynska A; Southey MC
Fam Cancer; 2018 Jul; 17(3):345-349. PubMed ID: 29052111
[TBL] [Abstract][Full Text] [Related]
12. Association Between Polymorphisms in DNA Damage Repair Pathway Genes and Female Breast Cancer Risk.
Wang Y; Sun Y; Tan M; Lin X; Tai P; Huang X; Jin Q; Yuan D; Xu T; He B
DNA Cell Biol; 2024 May; 43(5):219-231. PubMed ID: 38634815
[TBL] [Abstract][Full Text] [Related]
13. The Role of PALB2 in the DNA Damage Response and Cancer Predisposition.
Nepomuceno TC; De Gregoriis G; de Oliveira FMB; Suarez-Kurtz G; Monteiro AN; Carvalho MA
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858227
[TBL] [Abstract][Full Text] [Related]
14. Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.
Silvestri V; Zelli V; Valentini V; Rizzolo P; Navazio AS; Coppa A; Agata S; Oliani C; Barana D; Castrignanò T; Viel A; Russo A; Tibiletti MG; Zanna I; Masala G; Cortesi L; Manoukian S; Azzollini J; Peissel B; Bonanni B; Peterlongo P; Radice P; Palli D; Giannini G; Chillemi G; Montagna M; Ottini L
Cancer; 2017 Jan; 123(2):210-218. PubMed ID: 27648926
[TBL] [Abstract][Full Text] [Related]
15. Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2.
Catucci I; Casadei S; Ding YC; Volorio S; Ficarazzi F; Falanga A; Marchetti M; Tondini C; Franchi M; Adamson A; Mandell J; Walsh T; Olopade OI; Manoukian S; Radice P; Ricker C; Weitzel J; King MC; Peterlongo P; Neuhausen SL
Breast Cancer Res Treat; 2016 Nov; 160(1):121-129. PubMed ID: 27624329
[TBL] [Abstract][Full Text] [Related]
16. XRCC2 Arg188His polymorphism is not directly associated with breast cancer risk: evidence from 37,369 subjects.
Yu KD; Chen AX; Qiu LX; Fan L; Yang C; Shao ZM
Breast Cancer Res Treat; 2010 Aug; 123(1):219-25. PubMed ID: 20127279
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of microsomal epoxide hydrolase gene polymorphism and the risk of breast carcinoma.
Zhong JH; Li LQ; Mo XS; Gong WF; Ma L; Chen J; You XM
Genet Mol Res; 2015 Apr; 14(2):4133-41. PubMed ID: 25966185
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor +405G/C and -2578C/A polymorphisms and breast cancer risk: a meta-analysis.
Zhang Y; Yu YF; Wang JZ; Jia H
Genet Mol Res; 2015 Aug; 14(3):8909-18. PubMed ID: 26345822
[TBL] [Abstract][Full Text] [Related]
19. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
[TBL] [Abstract][Full Text] [Related]
20. Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese females.
Wang M; Wang Z; Wang XJ; Jin TB; Dai ZM; Kang HF; Guan HT; Ma XB; Liu XH; Dai ZJ
Drug Des Devel Ther; 2016; 10():2359-67. PubMed ID: 27524883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
